Canada Pharmaceuticals & Healthcare Q1 2021
Key View:
Pharmaceutical revenues face an increasingly challenging outlook in Canada over the coming years as a result of aconcerted focus on reducing patented medicine prices. We have revised downward our 10-year pharmaceutical market forecast toreflect recent medicine price regulation changes and might revise it further once the details of the single-payer Pharmacareprogramme become clearer over the coming quarters. Despite this current lack of details, we anticipate continued steps towardsthe implementation of a single-payer prescription medicine coverage programme, which will put additional pressure on medicineprices. Even if Pharmacare is implemented, Canada will remain a major global market in terms of pharmaceutical market size, whiledemand for chronic disease treatment will continue to increase.
- Key View
- Canada Pharmaceuticals & Healthcare Covid-19 Impact
- SWOT
- Industry Forecast
- Pharmaceutical Market Forecast
- Healthcare Market Forecast
- Prescription Drug Market Forecast
- Patented Drug Market Forecast
- Generic Drug Market Forecast
- OTC Medicine Market Forecast
- Pharmaceutical Trade Forecast
- Industry Risk/Reward Index
- Americas Innovative Pharmaceuticals Risk/Reward Index
- Innovative Pharmaceuticals Risk/Reward Index
- Regulatory Development
- Market Overview
- Competitive Landscape
- Company Profile
- Apotex
- GlaxoSmithKline
- Merck
- Novartis
- Bausch Health
- Canada Demographic Outlook
- Pharmaceuticals & Healthcare Glossary
- Pharmaceuticals & Healthcare Methodology
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook